Highlights and Quick Summary
- Free Cash Flow Growth for the quarter ending December 31, 2022 was -74.73% (a -1471.19% decrease compared to previous quarter)
- Year-over-year quarterly Free Cash Flow Growth increased by 5.61%
- Annual Free Cash Flow Growth for 2022 was -1.33% (a -93.45% decrease from previous year)
- Annual Free Cash Flow Growth for 2022 was -20.3% (a 520.8% increase from previous year)
- Annual Free Cash Flow Growth for 2021 was -3.27% (a -95.02% decrease from previous year)
- Twelve month Free Cash Flow Growth ending December 31, 2022 was -23.0% (a 270.37% increase compared to previous quarter)
- Twelve month trailing Free Cash Flow Growth decreased by -48.57% year-over-year
Trailing Free Cash Flow Growth for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -23.0% | -6.21% | -22.27% | -44.72% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Free Cash Flow Growth of Benitec Biopharma Limited
Most recent Free Cash Flow Growthof BNTC including historical data for past 10 years.Interactive Chart of Free Cash Flow Growth of Benitec Biopharma Limited
Benitec Biopharma Limited Free Cash Flow Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -74.73% | 5.45% | 2.95% | -70.76% | -1.33% |
| 2021 | 4.46% | -68.89% | -58.83% | -136.35% | -3.27% |
| 2020 | -13.67% | -365.63% | -51.48% | 75.65% | -3.64% |
| 2019 | – | – | -108.05% | 81.81% | -8.35% |
| 2018 | – | – | – | – | -2.59% |
| 2017 | – | – | – | 80.11% | -2.02% |
| 2016 | – | 59.17% | 66.52% | 64.95% | -1.79% |
| 2015 | – | – | -272.95% | -144.92% | 0.06% |
| 2014 | – | – | -198.65% | -185.28% | -203.21% |
| 2013 | 73.19% | – | – | – | 67.02% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology